Remove 2019 Remove Diabetes Remove Insurance Remove Medical
article thumbnail

Churning out of insurance among patients with diabetes served in US Community Health Centers [Economic or policy analysis]

Annals of Family Medicine

Health insurance instability may be particularly challenging for patients with diabetes who need regular chronic care management to reduce the risk of diabetes complications. 46,844 patients were diagnosed with diabetes during study period. Having a prescription of insulin was not associated with likelihood of churning.

article thumbnail

Identifying and Resolving Red Flags: DEA Continues to “Run it Up the Flagpole”

FDA Law

DEA regulations state that a pharmacist has a corresponding responsibility not to fill a prescription unless it is issued for a “legitimate medical purpose by an individual practitioner acting in the usual course of [their] professional practice.” 12, 2012) (quoting Bob’s Pharmacy & Diabetic Supplies; Revocation of Registration, 74 Fed.

IT 40
article thumbnail

Patient Groups Sue HHS, CMS for 2020 Rule Allowing the Use of Copay Accumulator Programs

FDA Law

As it stands, the rule allows insurers and pharmacy benefit managers (PBMs) to broadly use copay accumulator programs, which have long been criticized by patient advocacy groups as padding insurers’ pockets while leaving patients high and dry. 156.130(h) to explicitly allow insurers to broadly use copay accumulator programs.